| CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma EM Noll, C Eisen, A Stenzinger, E Espinet, A Muckenhuber, C Klein, ... Nature medicine 22 (3), 278-287, 2016 | 209 | 2016 |
| OrthoDB: the hierarchical catalog of eukaryotic orthologs EV Kriventseva, N Rahman, O Espinosa, EM Zdobnov Nucleic acids research 36 (suppl_1), D271-D275, 2007 | 153 | 2007 |
| Deriving a mutation index of carcinogenicity using protein structure and protein interfaces O Espinosa, K Mitsopoulos, J Hakas, F Pearl, M Zvelebil PloS one 9 (1), e84598, 2014 | 24 | 2014 |
| A gene-phenotype network for the laboratory mouse and its implications for systematic phenotyping O Espinosa, JM Hancock PLoS One 6 (5), e19693, 2011 | 14 | 2011 |
| Genetic interactions and tissue specificity modulate the association of mutations with drug response D Cramer, J Mazur, O Espinosa, M Schlesner, D Hübschmann, R Eils, ... Molecular cancer therapeutics 19 (3), 927-936, 2020 | 8 | 2020 |
| Protein coalitions in a core mammalian biochemical network linked by rapidly evolving proteins C Ainali, M Simon, S Freilich, O Espinosa, L Hazelwood, S Tsoka, ... BMC Evolutionary Biology 11, 1-13, 2011 | 1 | 2011 |
| Cellular deconvolution and expression analysis of Stromal and Epithelial cells directly isolated from human Pancreatic Ductal Adenocarcinoma (PDAC) E Espinet, Z Gu, CD Imbusch, V Vogel, C Klein, J Yang, O Espinosa, ... Pancreatology 17 (3), S18, 2017 | | 2017 |
| Abstract LB-120: CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma EM Noll, C Eisen, A Stenzinger, E Espinet, A Muckenhuber, C Klein, ... Cancer Research 76 (14_Supplement), LB-120-LB-120, 2016 | | 2016 |
| Deriving a Mutation Index of Carcinogenicity Using Protein Structure and Protein O Espinosa, K Mitsopoulos, J Hakas, F Pearl, M Zvelebil | | 2014 |
